MYnd Analytics and Emmaus Life Sciences Announce Merger and Spin-off Transaction
January 07, 2019 07:30 ET
|
MYnd Analytics, Inc.
Emmaus’ commercial lead product Endari™ (L-glutamine oral powder) is FDA approved to reduce the acute complications of sickle cell disease Endari addresses a $3 billion worldwide market MISSION...
MYnd Analytics Appoints Senior Industry Executive Patrick Herguth as Chief Executive Officer and Board Member; George Carpenter Assumes New Role as Chief Innovation Officer
December 12, 2018 07:30 ET
|
MYnd Analytics, Inc.
MISSION VIEJO, Calif., Dec. 12, 2018 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND), a predictive analytics company aimed at improving the delivery of mental health through the combination...
MYnd Analytics Awarded Subcontract to Support Suicide Prevention for the U.S. Department of Health and Human Services
November 27, 2018 08:00 ET
|
MYnd Analytics, Inc.
MISSION VIEJO, Calif., Nov. 27, 2018 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND), a market leader in improving the delivery of mental health through the combination of telemedicine and...
MYnd Analytics’ PEER Report Featured on CBS New York
November 05, 2018 08:00 ET
|
MYnd Analytics, Inc.
MISSION VIEJO, Calif., Nov. 05, 2018 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND), a market leader in improving the delivery of mental health through the combination of telemedicine and...
MYnd Analytics Announces Insider Buying Through Private Placement
September 26, 2018 10:39 ET
|
MYnd Analytics, Inc.
MISSION VIEJO, Calif., Sept. 26, 2018 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND), a market leader in improving the delivery of mental health through the combination of telemedicine and...
MYnd Analytics to Provide TeleEAP Services for Integrated Behavioral Health, a National Managed Behavioral Health Company
September 20, 2018 08:00 ET
|
MYnd Analytics, Inc.
MISSION VIEJO, Calif., Sept. 20, 2018 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND), a market leader in improving the delivery of mental health through the combination of telemedicine and...
MYnd Analytics Announces Nationwide Expansion of Telepsychiatry & Telebehavioral Health Services for Leading EAP Provider Claremont Behavioral Services
September 17, 2018 12:58 ET
|
MYnd Analytics, Inc.
MISSION VIEJO, Calif., Sept. 17, 2018 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND), a market leader in improving the delivery of mental health through the combination of telemedicine and...
FDA Designates Breakthrough Device Status for MYnd Analytics’ PEER 4.0
September 17, 2018 08:43 ET
|
MYnd Analytics, Inc.
MISSION VIEJO, Calif., Sept. 17, 2018 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND), a market leader in improving the delivery of mental health through the combination of telemedicine and...
MYnd Analytics Partners with Sanford Health to Provide Telepsychiatry Services Supporting Outpatient Primary Care Practices
September 13, 2018 10:41 ET
|
MYnd Analytics, Inc.
MISSION VIEJO, Calif., Sept. 13, 2018 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND), a market leader in improving the delivery of mental health through the combination of telemedicine and...
MYnd Analytics and Arcadian Telepsychiatry Services Announce Launch of Correctional Facilities Telepsychiatry Program; Designed to Provide Inmates Improved Access to Mental Health Services
September 11, 2018 10:00 ET
|
MYnd Analytics, Inc.
MISSION VIEJO, Calif., Sept. 11, 2018 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (NASDAQ: MYND), a market leader in improving the delivery of mental health through the combination of telemedicine and...